Q1 2024 Y-mAbs Therapeutics Inc Earnings Call Transcript

May 08, 2024 / 12:00PM GMT
Operator

Good morning, and welcome to Y-mAbs Therapeutics Inc. earnings conference call for the first quarter of 2024. (Operator Instructions) As reminder, today's conference will be recorded, and I will now hand it over to Y-mAbs' Head of IR, Courtney Dugan.

Courtney Dugan - Y-mAbs Therapeutics Inc - VP & Head of IR

Thank you, operator, and good morning, everyone. Welcome to the Y-mAbs First Quarter 2024 financial results conference call. We issued a press release this morning and yesterday excuse me, at market close. The press release and accompanying slides are available on the IR section of our website.

Let me quickly remind you that the following discussion contains certain statements that are considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995.

Such statements include, but are not limited to, statements about our business model and development, commercialization and product distribution plans expectations with respect to early trial data, current and future clinical and preclinical studies

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot